Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 2/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B13 | Q7Z5P4 | 6/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.38 |
| ▸ | CTSA | P10619 | 7/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL687559 | 0.90 | ALDH1A1 (0.49) | ALDH1A1CTSALMNA | |
| SCHEMBL688598 | 0.89 | ALDH1A1 (0.39) | ALDH1A1CTSALMNA | |
| SCHEMBL688132 | 0.88 | TP53 (0.44) | ALDH1A1NTRK1CTSATP53 | |
| SCHEMBL687761 | 0.87 | CTSA (0.46) | ALDH1A1CTSALMNATP53 | |
| SCHEMBL687280 | 0.86 | POLB (0.43) | ITGB1ITGA4CTSALMNA | |
| SCHEMBL688377 | 0.85 | LMNA (0.42) | ITGB1ITGA4LMNATP53 | |
| SCHEMBL688155 | 0.85 | PTGER3 (0.49) | ALDH1A1CTSA | |
| SCHEMBL688040 | 0.85 | PTGER3 (0.49) | ALDH1A1CTSA | |
| SCHEMBL688191 | 0.85 | ALDH1A1 (0.40) | ITGB1ITGA4ALDH1A1CTSA | |
| SCHEMBL687369 | 0.84 | WDR5 (0.44) | ITGB1ITGA4ALDH1A1HSD17B13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203766-B1 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |